Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

Published
23 March 2017
From
ITPC
Advanced HIV disease & Same day start of ART - Make your voice heard!

The World Health Organization is seeking the values & preferences of people living with HIV as it prepares new guidelines on two topics: whether ART should be started on the same day of a diagnosis of HIV, and the best combination of treatment for people living with HIV who look for care when they already have advanced HIV disease. Deadline: this Sunday, 19 March 2017.

Published
14 March 2017
From
WHO
Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

Published
06 March 2017
From
NHS England
From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors' practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention and even oncologists on Twitter, according to a series of papers on money and influence published Tuesday in JAMA Internal Medicine.

Published
18 January 2017
From
NPR
In the era of universal treatment, what are HIV clinical guidelines for?

The purpose and structure of clinical HIV guidelines may have to change radically now that universal treatment on diagnosis is the clinical consensus, physicians from the European

Published
22 December 2016
By
Gus Cairns
Ending the HIV epidemic faces daunting barriers, former WHO HIV chief warns

The difficulty of bringing the HIV epidemic “down to zero” should not be underestimated, Kevin de Cock, former director of HIV for the World Health Organization (WHO),

Published
30 November 2016
By
Gus Cairns
Kiwi HIV patients 'denied access to medication'

The New Zealand AIDS Foundation (NZAF) says Kiwis with newly diagnosed HIV infections are being unfairly penalised by outdated policies denying them access to important medication. Currently people diagnosed with HIV in New Zealand cannot access medication until their CD4 cell (white blood cell) count has dropped below 500.

Published
24 November 2016
From
Newshub
UNITAID and ANRS launch initiative in Cameroon to bring new HIV treatments to Africa

A study launched in Yaoundé will test the latest generation of HIV treatment based on Dolutegravir under local conditions, with a view to establishing its viability in Africa. The results of the study are intended to inform the World Health Organization’s guidelines for the treatment of HIV patients in Africa. If successful, they will help to accelerate the opening of the market for these combinations to manufacturers of generic medicines and thereby reduce prices as well as improve access.

Published
17 November 2016
From
UNITAID
Promising trends continue in UK diagnosis and treatment rates

A ‘mini report’ of the latest figures on HIV diagnoses, late diagnosis, and treatment uptake in the UK reports generally good results, with downward trends in infections, the

Published
07 October 2016
By
Gus Cairns
Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation

People considering direct-acting antiviral (DAA) therapy for hepatitis C should first be tested for hepatitis B virus (HBV) and monitored throughout therapy, as elimination of hepatitis C virus

Published
07 October 2016
By
Liz Highleyman
← First12345...32Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.